Tiziana Life Sciences Ltd (TLSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 06-2024 | 12-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,251 | 3,724 | 1,130 | 1,183 | 6,597 |
| Receivables | 4,948 | 3,639 | 6,265 | 5,931 | 7,893 |
| Other current assets | 0 | 145 | 355 | 223 | 691 |
| TOTAL | $12,716 | $7,508 | $7,750 | $7,337 | $15,181 |
| Non-Current Assets | |||||
| PPE Net | 18 | N/A | N/A | N/A | N/A |
| Investments And Advances | 3,731 | 3,589 | 2,969 | 4,554 | 1,886 |
| Other Non-Current Assets | 132 | 0 | 0 | 0 | 0 |
| TOTAL | $3,881 | $3,589 | $2,969 | $4,554 | $1,886 |
| Total Assets | $16,597 | $11,284 | $10,964 | $12,184 | $17,418 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,177 | 7,230 | 8,922 | 6,387 | 3,764 |
| Other current liabilities | 9 | 12 | 8 | 14 | 6 |
| TOTAL | $7,397 | $7,348 | $9,072 | $6,539 | $3,940 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $7,397 | $7,348 | $9,109 | $6,648 | $4,123 |
| Shareholders' Equity | |||||
| Common Shares | 119 | 111 | 104 | 103 | 102 |
| Retained earnings | -150,463 | -144,831 | -138,271 | -133,676 | -124,880 |
| Other shareholders' equity | 127,756 | 125,551 | 125,108 | 124,617 | 124,477 |
| TOTAL | $9,200 | $3,936 | $1,855 | $5,536 | $13,295 |
| Total Liabilities And Equity | $16,597 | $11,284 | $10,964 | $12,184 | $17,418 |